These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1969414)

  • 1. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase.
    Kahn NN; Sinha AK
    J Biol Chem; 1990 Mar; 265(9):4976-81. PubMed ID: 1969414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1991 Jan; 68(1):245-54. PubMed ID: 1845854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelet adenylate cyclase: persistent binding of guanine nucleotide is central to the regulation of both hormone-stimulated and basal activities.
    Olson CV; Smiley PA; Lad PM
    Biochim Biophys Acta; 1985 Jun; 845(3):411-20. PubMed ID: 3924118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM; Goldberg BJ; Smiley PA; Olson CV
    Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin receptors in the expression of prostaglandin E1 binding activity in platelets.
    Kahn NN; Sinha AK
    Adv Exp Med Biol; 1990; 281():271-6. PubMed ID: 1966355
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of increased platelet cyclic AMP induced by prostaglandin E1 after removal of the hormone.
    Sinha AK; Colman RW
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2946-50. PubMed ID: 6248875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K; Kajikawa N; Nishio S; Yajima M
    Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin receptor-adenylate cyclase system in plasma membranes of rat liver and ascites hepatomas, and the effect of GTP upon it.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1977 Feb; 465(1):54-67. PubMed ID: 189813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: coupling of receptors with high-affinity GTPase and adenylate cyclase.
    Avdonin PV; Svitina-Ulitina IV; Leytin VL; Tkachuk VA
    Thromb Res; 1985 Oct; 40(1):101-12. PubMed ID: 3003958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets.
    Dutta-Roy AK; Sinha AK
    J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.